Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development; Draft Guidance for Industry; Availability
🏛 Food and Drug Administration (FDA)FDA-2022-D-0112
Documents
1
Total comments
1
all analyzed
Comment status
Open
Last activity
Jul 27, 2026
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
OtherOct 18, 2024
Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development; Guidance for IndustryNo comment period💬 1 comment